Trials Sponsors Conditions Drugs Pricing

Conditions

Dementia Dementia Alzheimer Type

Keywords

DementiaSpectroscopyDynamic Light Scattering SpectroscopyRetinal Nerve Fiber LayerDLS

Outcome Measures

Primary Outcomes (1)

Comparison of Dynamic Light Scattering Spectroscopy in Dementias
Dynamic light scattering will be compared between patients with dementias and patients with no cerebral pathology.
Single measurement taken over 5 minutes

Study Arms (2)

Patients diagnosed with dementia

Patients diagnosed with dementia including those caused by Alzheimer's, Vascular, Lewy body, Mixed, Parkinson's, Frontotemporal, Creutzfeldt-Jakob, Normal pressure hydrocephalus, Huntington's, Wernicke-Korsakoff Syndrome.

Patients without cerebral pathology

Patients without cerebral pathology (no dementia)

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Diagnostic radiology practice

1. All patients must be capable of an adequate ophthalmic evaluation and testing. This includes the ability to cooperate with the exam, sufficiently clear media (cornea, lens, vitreous) and sufficient pupillary dilation. 2. Patients must be capable of providing informed consent. 3. Patients who are not medically stable or who may be at significant risk to their health will not be eligible. 4. Women of child bearing age must not be pregnant at the time of examination.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Jeffrey N Weiss MD
Type not reportedcollaborator
The Healing Institute
Type not reportedcollaborator
MD Stem Cells

Study Sites (1)

3T Radiology

Coconut Creek, Florida, 33073, United States

RECRUITING

Daryl Eber, MDCONTACT954-686-2559 dreber@3tradiology.com

Jeffrey N Weiss, MDCONTACT954-608-7604 jweissmd@me.com

MeSH Terms

Conditions

DementiaAlzheimer Disease

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative Diseases

Study Officials

Jeffrey N Weiss, MD
The Healing Institute
PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeffrey N Weiss, MD

CONTACT

954-608-7604 jweissmd@me.com

Daryl Eber, MD

CONTACT

954-686-2559

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: CROSS SECTIONAL
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 23, 2024

First Posted

September 26, 2024

Study Start

April 25, 2024

Actual (reported)

Primary Completion

April 25, 2027

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Dynamic Light Scattering Ocular Measurement in the Detection of Dementia

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Patients diagnosed with dementia

Patients without cerebral pathology

Eligibility Criteria

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Patients diagnosed with dementia

Patients without cerebral pathology

Eligibility Criteria

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Source record

Locations